Regenxbio Sale Purchase Of Stock from 2010 to 2024

RGNX Stock  USD 9.92  0.09  0.90%   
Regenxbio Sale Purchase Of Stock yearly trend continues to be fairly stable with very little volatility. Sale Purchase Of Stock is likely to outpace its year average in 2024. During the period from 2010 to 2024, Regenxbio Sale Purchase Of Stock regression line of annual values had r-squared of  0.02 and arithmetic mean of  16,193,797. View All Fundamentals
 
Sale Purchase Of Stock  
First Reported
2014-12-31
Previous Quarter
411 K
Current Value
780 K
Quarterly Volatility
32.3 M
 
Yuan Drop
 
Covid
Check Regenxbio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Regenxbio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.2 M, Interest Expense of 6.5 M or Selling General Administrative of 47.8 M, as well as many indicators such as Price To Sales Ratio of 8.26, Dividend Yield of 0.0 or PTB Ratio of 2.64. Regenxbio financial statements analysis is a perfect complement when working with Regenxbio Valuation or Volatility modules.
  
Check out the analysis of Regenxbio Correlation against competitors.
For more information on how to buy Regenxbio Stock please use our How to Invest in Regenxbio guide.

Latest Regenxbio's Sale Purchase Of Stock Growth Pattern

Below is the plot of the Sale Purchase Of Stock of Regenxbio over the last few years. It is Regenxbio's Sale Purchase Of Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Regenxbio's overall financial position and show how it may be relating to other accounts over time.
Sale Purchase Of Stock10 Years Trend
Pretty Stable
   Sale Purchase Of Stock   
       Timeline  

Regenxbio Sale Purchase Of Stock Regression Statistics

Arithmetic Mean16,193,797
Geometric Mean69,769
Coefficient Of Variation381.17
Mean Deviation29,748,827
Median1,000.00
Standard Deviation61,726,428
Sample Variance3810.2T
Range239.7M
R-Value(0.12)
Mean Square Error4040.8T
R-Squared0.02
Significance0.66
Slope(1,702,430)
Total Sum of Squares53342.1T

Regenxbio Sale Purchase Of Stock History

2024-398.1 K
2023-419 K
2022-284 K
2021 -2000.0
20201.8 M
20191.3 M
2018847 K

About Regenxbio Financial Statements

Regenxbio investors use historical fundamental indicators, such as Regenxbio's Sale Purchase Of Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Regenxbio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Sale Purchase Of Stock-419 K-398.1 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Regenxbio Stock Analysis

When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.